ProfileGDS4718 / 210418_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 92% 92% 93% 92% 95% 94% 93% 92% 94% 95% 91% 93% 98% 93% 94% 95% 88% 96% 78% 94% 94% 94% 95% 93% 97% 93% 94% 93% 95% 88% 97% 90% 92% 93% 95% 84% 92% 93% 93% 94% 88% 94% 94% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.342895
GSM549102patient 115, normal, homogenized [OPG study]9.6164592
GSM549104patient 119, normal, homogenized [OPG study]9.5640392
GSM549108patient 138, normal, homogenized [OPG study]9.6989293
GSM549119patient 077, normal, homogenized [OPG study]9.6271192
GSM549133patient 032, cancer, homogenized [OPG study]10.315695
GSM549139patient 042, cancer, homogenized [OPG study]10.015694
GSM549099patient 107, normal, homogenized [OPG study]9.7965793
GSM549109patient 139, normal, homogenized [OPG study]9.5543692
GSM549110patient 046, normal, homogenized [OPG study]10.00794
GSM549114patient 063, normal, homogenized [OPG study]10.417595
GSM549122patient 082, normal, homogenized [OPG study]9.3823991
GSM549134patient 033, cancer, homogenized [OPG study]9.8147893
GSM549136patient 036, cancer, homogenized [OPG study]11.357498
GSM549140patient 044, cancer, homogenized [OPG study]9.8401293
GSM549111patient 047, normal, homogenized [OPG study]10.114194
GSM549113patient 057, normal, homogenized [OPG study]10.409995
GSM549132patient 031, cancer, homogenized [OPG study]8.8667788
GSM549137patient 038, cancer, homogenized [OPG study]10.316396
GSM549142patient 047, cancer, homogenized [OPG study]7.4563678
GSM549100patient 110, normal, homogenized [OPG study]10.047894
GSM549107patient 135, normal, homogenized [OPG study]10.025794
GSM549115patient 068, normal, homogenized [OPG study]10.146994
GSM549116patient 072, normal, homogenized [OPG study]10.332795
GSM549120patient 078, normal, homogenized [OPG study]9.8230893
GSM549131patient 030, cancer, homogenized [OPG study]10.905397
GSM549118patient 074, normal, homogenized [OPG study]9.886293
GSM549129patient 027, cancer, homogenized [OPG study]9.6993994
GSM549123patient 088, normal, homogenized [OPG study]9.9100993
GSM549124patient 006, cancer, homogenized [OPG study]9.953395
GSM549126patient 015, cancer, homogenized [OPG study]8.8618488
GSM549128patient 025, cancer, homogenized [OPG study]11.027397
GSM549103patient 117, normal, homogenized [OPG study]9.1429490
GSM549117patient 073, normal, homogenized [OPG study]9.8442192
GSM549138patient 041, cancer, homogenized [OPG study]9.7929393
GSM549141patient 045, cancer, homogenized [OPG study]10.334995
GSM549130patient 028, cancer, homogenized [OPG study]8.3271784
GSM549101patient 111, normal, homogenized [OPG study]9.4512892
GSM549105patient 128, normal, homogenized [OPG study]9.780193
GSM549106patient 134, normal, homogenized [OPG study]9.9621593
GSM549112patient 048, normal, homogenized [OPG study]10.105494
GSM549125patient 011, cancer, homogenized [OPG study]8.8269888
GSM549127patient 024, cancer, homogenized [OPG study]9.9237894
GSM549135patient 035, cancer, homogenized [OPG study]9.9249794